Mr. Mowry joined Tornier in July 2011 as chief operating officer. He brings to Tornier more than 20 years of medical device industry experience in various engineering and management assignments. Prior to Tornier, Mr. Mowry served as senior vice president and president of the neurovascular division of Covidien and the same position with ev3 prior to its acquisition by Covidien.
Tornier Names David Mowry Interim President, CEO
Tornier has appointed David H. Mowry as interim president and CEO, effective immediately.
How health plans can close the execution gap in value-based care — A practical AI-driven approach
Recommended Live Webinar on Mar 31, 2026 11:00 AM - 12:00 PM CST